Literature DB >> 30865616

Current Sepsis Mandates Are Overly Prescriptive, and Some Aspects May Be Harmful.

Michael Klompas1,2, Chanu Rhee1,2.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 30865616     DOI： 10.1097/CCM.0000000000003579

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  5 in total

Review 1.  Driving blind: instituting SEP-1 without high quality outcomes data.

Authors:  Jeffrey Wang; Jeffrey R Strich; Willard N Applefeld; Junfeng Sun; Xizhong Cui; Charles Natanson; Peter Q Eichacker
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

2.  The management of sepsis: science & fiction.

Authors:  Paul E Marik
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

3.  Identifying High-Risk Subphenotypes and Associated Harms From Delayed Antibiotic Orders and Delivery.

Authors:  Xuan Han; Alexandra Spicer; Kyle A Carey; Emily R Gilbert; Neda Laiteerapong; Nirav S Shah; Christopher Winslow; Majid Afshar; Markos G Kashiouris; Matthew M Churpek
Journal:  Crit Care Med       Date:  2021-10-01       Impact factor: 9.296

4.  Equipoise in Appropriate Initial Volume Resuscitation for Patients in Septic Shock With Heart Failure: Results of a Multicenter Clinician Survey.

Authors:  Gabriel Wardi; Ian Joel; Julian Villar; Michael Lava; Eric Gross; Vaishal Tolia; Raghu R Seethala; Robert L Owens; Rebecca E Sell; Sydney B Montesi; Farbod N Rahaghi; Somnath Bose; Ashish Rai; Elizabeth K Stevenson; Jakob McSparron; Vaishal Tolia; Jeremy R Beitler
Journal:  J Intensive Care Med       Date:  2019-08-25       Impact factor: 2.889

5.  Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals.

Authors:  Chanu Rhee; Tingting Yu; Rui Wang; Sameer S Kadri; David Fram; Huai-Chun Chen; Michael Klompas
Journal:  JAMA Netw Open       Date:  2021-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.